More on FTH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $23.19 |
|
|||
| Open | $23.30 | ||||
| 52 Wk High | $0.25 | ||||
| 52 Wk Low | $0.25 | ||||
| Day High | $28.98 | ||||
| Day Low | $22.83 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 140,305 | ||||
- Form 3 Faeth Therapeutics, Inc. For: Jun 13 Filed by: STEPHENSON BRIAN C
- Form SCHEDULE 13G Faeth Therapeutics, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
- Form SCHEDULE 13G Faeth Therapeutics, Inc. Filed by: S2G Investments, LLC
- H.C. Wainwright Starts Faeth Therapeutics (FTH) at Buy
- Form 8-K Faeth Therapeutics, Inc. For: Jun 15
- faeth (FTH) files mixed shelf
- Form S-3ASR Faeth Therapeutics, Inc.
- Sensei Biotherapeutics changes name to Faeth Therapeutics
- Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
Entities mentioned with FTH
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
